ClinicalTrials.Veeva

Menu

The Effect of Iloprost on Oxygenation During One-lung Ventilation for Lung Surgery

S

Seoul St. Mary's Hospital

Status

Completed

Conditions

Lung Cancer

Treatments

Drug: Inhaled iloprost
Drug: Distilled water

Study type

Interventional

Funder types

Other

Identifiers

NCT03936140
KC14MISI0880

Details and patient eligibility

About

During one-lung ventilation in patients undergoing thoracic surgery, the persistent flow in the non-ventilated lung increases intrapulmonary shunt and decreases systemic arterial oxygenation. This prospective, randomized, double blind study was conducted to evaluate the effects of inhaled iloprost during one-lung ventilation on arterial oxygenation and shunt fraction during thoracic surgery.

Enrollment

72 patients

Sex

All

Ages

20 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • elective video-assisted thoracoscopic surgery (VATS) lobectomy
  • 20 < age < 75
  • American Society of Anesthesiologists (ASA) classification I~III

Exclusion criteria

  • ASA classification IV
  • New York Heart Association (NYHA) class III~IV
  • Severe obstructive lung disease / restrictive lung disease
  • Pulmonary hypertension
  • End-stage organ disease (i.e. hepatic failure, renal failure)
  • Arrhythmia
  • Previous history of thoracic surgery

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

72 participants in 3 patient groups, including a placebo group

Iloprost 10
Experimental group
Description:
Iloprost 10μg of inhaled iloprost (Ventavis®) Study drug was inhaled to ventilated lung through a nebulized system in inspiratory limb after one-lung ventilation in the lateral decubitus position.
Treatment:
Drug: Inhaled iloprost
Iloprost 20
Experimental group
Description:
Iloprost 20μg of inhaled iloprost (Ventavis®) Study drug was inhaled to ventilated lung through a nebulized system in inspiratory limb after one-lung ventilation in the lateral decubitus position.
Treatment:
Drug: Inhaled iloprost
Distilled water
Placebo Comparator group
Description:
Distilled water Study drug was inhaled to ventilated lung through a nebulized system in inspiratory limb after one-lung ventilation in the lateral decubitus position.
Treatment:
Drug: Distilled water

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems